Single Nucleotide Polymorphisms and the Likelihood of Prostate Cancer at a Given Prostate Specific Antigen Level

Journal of Urology

Volumn 182, Issue 1, 2009, Pages 101-105

  Loeb, Stacy ^a   Carter, H Ballentine ^a   Walsh, Patrick C ^a   Isaacs, William B ^a   Kettermann, Anna ^a   Tanaka, Toshiko ^b   Ferrucci, Luigi ^b   Metter, E Jeffrey ^b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

genetics; mass screening; polymorphism; prostate specific antigen; prostatic neoplasms; single nucleotide

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ALLELE; ARTICLE; CANCER RISK; CANCER SCREENING; CHROMOSOME 10; CHROMOSOME 19; CONTROLLED STUDY; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGE FACTORS; AGED; AGING; BIOPSY, NEEDLE; CHROMOSOMES, HUMAN, PAIR 10; CHROMOSOMES, HUMAN, PAIR 19; COHORT STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS;

EID: 67349141550     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.02.126     Document Type: Article

References (10)

1. Amundadottir L.T., Sulem P., Gudmundsson J., Helgason A., Baker A., Agnarsson B.A., et al. A common variant associated with prostate cancer in European and African populations. Nat Genet 38 (2006) 652
2. Suuriniemi M., Agalliu I., Schaid D.J., Johanneson B., McDonnell S.K., Iwasaki L., et al. Confirmation of a positive association between prostate cancer risk and a locus at chromosome 8q24. Cancer Epidemiol Biomarkers Prev 16 (2007) 809
3. Gudmundsson J., Sulem P., Steinthorsdottir V., Bergthorsson J.T., Thorleifsson G., Manolescu A., et al. Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat Genet 39 (2007) 977
4. Zheng S.L., Sun J., Wiklund F., Smith S., Stattin P., Li G., et al. Cumulative association of five genetic variants with prostate cancer. N Engl J Med 358 (2008) 910
5. Eeles R.A., Kote-Jarai Z., Giles G.G., Olama A.A., Guy M., Jugurnauth S.K., et al. Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet 40 (2008) 316
6. Beke L., Nuytten M., Van Eynde A., Beullens M., and Bollen M. The gene encoding the prostatic tumor suppressor PSP94 is a target for repression by the Polycomb group protein EZH2. Oncogene 26 (2007) 4590
7. Thompson I.M., Ankerst D.P., Chi C., Lucia M.S., Goodman P.J., Crowley J.J., et al. Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower. JAMA 294 (2005) 66
8. Carter H.B., Pearson J.D., Metter E.J., Brant L.J., Chan D.W., Andres R., et al. Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA 267 (1992) 2215
9. Savblom C., Giwercman A., Malm J., Hallden C., Lundin K., Lilja H., et al. Association between polymorphisms in the prostate-specific antigen (PSA) promoter and release of PSA. Int J Androl (2008) Epub ahead of print
10. Dall'Era M., and Carroll P.R. Prostate cancer-more information and more questions. J Urol 177 (2007) 1607